Masaya Nishida
Overview
Explore the profile of Masaya Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aoyama Y, Toyotama A, Okuzono T, Ishikawa T, Hyodo K, Nishida M, et al.
Langmuir
. 2025 Jan;
41(3):1948-1956.
PMID: 39813153
In this study, we demonstrate a novel and efficient fabrication methodology for nonclose-packed, two-dimensional (2D) colloidal crystals exhibiting square lattice structures. In our recent work, we detailed the formation of...
2.
Iwamoto N, Sato N, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, et al.
Clin Exp Nephrol
. 2015 Dec;
20(5):808-814.
PMID: 26677857
Background: The aim of the study is to elucidate whether parathyroid hormone (PTH) levels after parathyroidectomy affect the prognosis of patients with secondary hyperparathyroidism. Subjects And Methods: Two hundred and...
3.
Nishimura M, Tokoro T, Takatani T, Sato N, Nishida M, Hashimoto T, et al.
Springerplus
. 2015 Jul;
4:353.
PMID: 26191480
We investigated whether chronic intravenous administration of l-carnitine could improve myocardial fatty acid imaging in patients on maintenance hemodialysis. We enrolled 72 hemodialysis patients who had impaired myocardial fatty acid...
4.
Nishimura M, Okamoto Y, Takatani T, Sato N, Nishida M, Hashimoto T, et al.
J Nephrol
. 2014 Jul;
28(2):227-34.
PMID: 25070153
Background: We investigated the potential of oral nicorandil to improve myocardial fatty acid metabolism assessed by single-photon emission computed tomography (SPECT) using (123)I-β-methyliodophenyl pentadecanoic acid (BMIPP) in hemodialysis patients without...
5.
Nishimura M, Okamoto Y, Tokoro T, Sato N, Nishida M, Hashimoto T, et al.
Nephron Clin Pract
. 2014 Jan;
126(1):24-32.
PMID: 24434794
Background/aims: The assessment of myocardial fatty acid metabolism impairment by single-photon emission computed tomography (SPECT) using (123)I-β-methyliodophenyl-pentadecanoic acid (BMIPP) might predict the risk of cardiac death in hemodialysis patients. We...
6.
Iwamoto N, Sato N, Nishida M, Hashimoto T, Kobayashi H, Yamasaki S, et al.
J Nephrol
. 2011 Dec;
25(5):755-63.
PMID: 22135031
Background And Aims: To compare the prognosis of chronic hemodialysis patients with or without parathyroidectomy. Methods: Among 158 chronic hemodialysis patients who underwent total parathyroidectomy between July 1998 and April...
7.
Nishimura M, Sakoda C, Murakawa M, Okamoto Y, Tokoro T, Sato N, et al.
Nephron Clin Pract
. 2011 Sep;
119(4):c301-9.
PMID: 21934329
Background/aims: We examined the potential of oral administration of nicorandil for protecting against cardiac death in hemodialysis patients without obstructive coronary artery disease. Methods: This study was based on a...
8.
Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, et al.
Nephron Clin Pract
. 2009 Feb;
111(3):c212-21.
PMID: 19225237
Background/aims: We examined whether nicorandil, which is a hybrid of an adenosine triphosphate-sensitive potassium channel opener and a nitrate, could inhibit major adverse cardiac events (MACE) in maintenance hemodialysis patients...
9.
Kanemitsu N, Kawauchi A, Nishida M, Tanaka Y, Mizutani Y, Shirahama S, et al.
Pediatr Nephrol
. 2002 Dec;
17(12):1063-5.
PMID: 12478359
A 10-year-old male referred to our clinic with the chief complaint of nocturnal enuresis also complained of daytime polyuria, frequency, and polydipsia. The clinical diagnosis was central diabetes insipidus. Since...